"Biotechnologijų projektai", MB Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 102,196 |
| - |
| 16,169 |
| 13,665 |
| - |
| 34.45 |
| 13.37 |
| 79,516 |
| 13,716 |
| 1,604 |
| 91,628 |
| 2023 |
|---|
| 101,817 |
| - |
| 15,073 |
| 11,825 |
| - |
| 39.34 |
| 11.61 |
| 91,341 |
| 2,917 |
| 802 |
| 93,456 |
| 2024 |
|---|
| 119,171 |
| - |
| 18,022 |
| 16,977 |
| - |
| 38.68 |
| 14.25 |
| 108,318 |
| 1,792 |
| 9,945 |
| 99,384 |
Enjoy unlimited use
with Freemium unlimited| 2024 |
|---|
| 119,171 |
| - |
| 18,022 |
| 16,977 |
| - |
| 38.68 |
| 14.25 |
| 108,318 |
| 1,792 |
| 9,945 |
| 99,384 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2024
Turnover (€)
119,171 €17 % *
Sales per employee (€)
-Profit before tax (€)
18,022 €20 % *
Net Profit (€)
16,977 €44 % *
Profit per employee (€)
-Total profitability (%)
38.68 %-1.68 % *
Net profitability (%)
14.25 %22.74 % *
Equity (€)
108,318 €19 % *
Amounts Payable And Liabilities (€)
1,792 €-39 % *
Non-current Assets (€)
9,945 €1,140 % *
CurrentAssets (€)
99,384 €6 % *
